Trinity Biotech | TRIB - Cost Of Sales


Trinity Biotech reported $7.84M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Bayer EUR 4.5B 194M Dec/2025
Bio-Rad Laboratories USD 309.6M 3.3M Sep/2025
EDAP TMS EUR 7.91M 1.31M Sep/2025
J&J USD 8.07B 103M Mar/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
OraSure Technologies USD 15.43M 113K Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Siemens EUR 11.51B 1.82B Dec/2025
Surmodics USD 9.49M 23.54M Jun/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Tosoh JPY 190.27B 3.82B Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025
Veracyte USD 39.28M 1.93M Dec/2025